These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9687392

  • 1. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.
    Thorburn CE, Knott SJ, Edwards DI.
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1973-9. PubMed ID: 9687392
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM, Rybak MJ.
    Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.
    Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H, Trupl J.
    Folia Microbiol (Praha); 1998 Aug; 43(1):68-70. PubMed ID: 9569631
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.
    Kays MB, Wood KK, Miles DO.
    Pharmacotherapy; 1999 Nov; 19(11):1308-14. PubMed ID: 10555936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [Abstract] [Full Text] [Related]

  • 9. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [Abstract] [Full Text] [Related]

  • 10. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P.
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics.
    Mason EO, Lamberth L, Lichenstein R, Kaplan SL.
    J Antimicrob Chemother; 1995 Dec; 36(6):1043-8. PubMed ID: 8821604
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Nyssen HJ, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 Dec; 51(6):377-85. PubMed ID: 8997755
    [Abstract] [Full Text] [Related]

  • 16. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.
    Negri MC, Morosini MI, Loza E, Baquero F.
    Antimicrob Agents Chemother; 1994 Jan; 38(1):122-5. PubMed ID: 8141563
    [Abstract] [Full Text] [Related]

  • 17. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771
    [Abstract] [Full Text] [Related]

  • 18. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S, Williams D.
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.
    Mason EO, Lamberth LB, Kershaw NL, Prosser BL, Zoe A, Ambrose PG.
    J Antimicrob Chemother; 2000 May; 45(5):623-31. PubMed ID: 10797084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.